Navigation Links
Long-term Use of Stomach Drugs may Weaken Bones

Usage of certain stomach drugs may weaken the bones in the long run and increase the risk of hip fracture, warns a new study that advises doctors to consider the risk when// prescribing such drugs.

Researchers at the University of Pennsylvania Medical School studied records from the general practice research database of Britain. All the people involved were aged over 50 and some had been taking proton pump inhibitors (PPI).

PPI's are a group of drugs whose main action is pronounced and long-lasting reduction of gastric acid production.

The research found that people who had been taking the drugs for over a year had a 44 percent greater risk of suffering a hip fracture, reported the online edition of BBC News.

Taking the drugs for even longer seemed to increase the risk further, according to the study that appeared in the Journal of the American Association.

Hip fracture is one of the most significant causes of severe disability in older people - up to one in five people who suffer a fracture following a fall die within 12 months.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Long-term use of calcium supplements to prevent colon cancer
2. Long-term Care Should Be A Planned Affair
3. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
4. Global AIDS Conference Calls for Long-term Strategies
5. Asthma Sufferers Favor Quick Relief Over Long-term Control
6. Long-term Marijuana Smoking Leads to Respiratory Complaints
7. Tamoxifen Yields Long-term Reduction in Breast Cancer Risk
8. Animal Fat Enhances Risk Of Stomach
9. Stomach infections may be associated with irregular heart rhythm
10. Proteinomics Research holds Key to Stomach Cancer
11. Can Home Remedy For Stomachache Work?
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Long term Use Stomach Drugs may Weaken Bones

(Date:9/1/2015)... ... 2015 , ... Ogawa’s new massage chairs tout innovative functionality that change the ... ever before. With the goal of bringing wellness to the world, Ogawa introduces their ... , As in its name, the Ogawa Refresh aims to “refresh” and ...
(Date:9/1/2015)... ... September 01, 2015 , ... USA Medical Card, a leading ... to coincide with back-to-school and the start of “sick season” for many households ... school children are sick an average of 8 to 12 times each school ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of natural ... Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy acids and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Dr. Trace Curry successfully placed one of the ... the last month the FDA has approved two intra-gastric balloons, the ORBERA ™ ... the first incisionless, reversible, weight loss procedures available to Americans. , Dr. ...
(Date:9/1/2015)... (PRWEB) , ... September 01, ... ... announce PRO Archiver for Alfresco, a next-generation customer communications archiving solution integrated ... with market-leading technology from Crawford and helps organizations save millions of dollars ...
Breaking Medicine News(10 mins):Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3
... TITAN Technology Partners, a,global provider of hosted and ... company in North Carolina in 2006, announced,today Valley ... signed a multi-year agreement to leverage TITAN,s Hosting ... Capital Management,applications throughout the organization for over 2,500 ...
... Feb. 29 Landauer, Inc. (NYSE:,LDR) announced today that ... of $0.50 per share for the second quarter of ... 2008, to shareholders of record,on March 14, 2008., ... analytical services to determine,occupational and environmental radiation exposure. For ...
... supplements do not protect against lung cancer, according to ... fact, some supplements may even increase the risk of ... C, vitamin E and folate did not show any ... the studys author, Christopher G. Slatore, M.D., of the ...
... to treat an aggressive form of breast cancer are ... in 50 countries across six continents -- a clinical ... for global cancer research. This trial, dubbed ALTTO (Adjuvant ... of the first global initiatives in which two large, ...
... into allergic reactions, deaths related to blood thinner continues ... Corp., the pharmaceutical company at the center of recent ... it was recalling any remaining multi-dose vials of the ... also said it was recalling its Hep-Lock heparin flush ...
... In a tradition dating,back to Franklin Delano Roosevelt, ... calling it a time to "honor this charitable,organization" and ... In a Proclamation signed today, the President cited ... and medical assistance to the victims,of a number of ...
Cached Medicine News:Health News:Valley Baptist Health System Leveraging TITAN Technology Partners Hosting and Managed Services 2Health News:Certain vitamin supplements may increase lung cancer risk, especially in smokers 2Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 2Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 3Health News:New study of targeted therapies for breast cancer -- model for global clinical trials 4Health News:Baxter Recalls Rest of Heparin Products 2Health News:Baxter Recalls Rest of Heparin Products 3Health News:President Bush Declares March as Red Cross Month 2Health News:President Bush Declares March as Red Cross Month 3
(Date:8/31/2015)...  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... subsidiary, Dougherty,s Holdings, has acquired Springtown Drug (" ... Springtown, Texas , just north of ... pharmacy has provided retail prescriptions, healthcare products and gifts ... . The Springtown ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015 The ... reversed statewide since Pennsylvania State ... life-saving drug kits, naloxone. Heroin and opioid ... Pennsylvania , killing more individuals than ... approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... June 9 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced new ... mellitus program at,the American Diabetes Association,s 68th ... company,s proprietary recombinant human,hyaluronidase enzyme (rHuPH20) with ...
... Pivotal Study Highlighted at Recent Arizona Alzheimer,s ... Consortium Annual Conference in Phoenix -, PHOENIX and ... Health Research Institute today announced that they are,actively enrolling patients ... treatment of Alzheimer,s disease. The study will,evaluate the safety and ...
Cached Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3